CDK4 and breast carcinoma: Furthermore, anti-estrogen therapies induce cell cycle arrest at the G1 phase, and subsets of breast cancer cells resistant to CDK4/6i exhibit defects in the G1 checkpoint, relying more on the G2/S checkpoint for DNA repair.